Bajaj Healthcare Limited — Important, 16-01-2025: General Updates

Bajaj Healthcare Limited has secured exclusive rights for the manufacturing, distribution, and sales of Magnesium L Threonate (Magtein®) in India from Threotech LLC. This licensing agreement enables Bajaj to market this innovative product and collaborate with leading pharmaceutical firms in India. The brand Magtein® holds significant potential, boasting a sales value of approximately USD 438 million in the U.S. market, where Bajaj already supplies the active pharmaceutical ingredient (API).

Managing Director Anil Jain highlighted that this collaboration solidifies Bajaj’s position as a trusted partner for international clients and emphasizes the company’s expertise in manufacturing and distribution. This step is expected to unlock substantial growth opportunities for Bajaj in the Indian market, presenting a positive outlook as they integrate quality excellence with strategic market initiatives.